Quantitative assessment of the effect of CYP2D6 genotype on tamoxifen metabolism: A model for CYP2D6 genotype-phenotype studies.

被引：0
|
作者：
Borges, S [1 ]
Desta, Z [1 ]
Jin, Y [1 ]
Li, L [1 ]
Skaar, TC [1 ]
Flockhart, DA [1 ]
机构：
[1] Indiana Univ, Indianapolis, IN 46204 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2005.12.120
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P34 / P34
页数：1
相关论文
共 50 条
  • [21] Effect of CYP2D6 genotype on duloxetine serum concentration
    Hole, Kristine
    Gangso, Sofie
    Jensstuen, Asa Tonette
    Ormoy, Hanne Holte
    Paulsen, Maren
    Molden, Espen
    Haslemo, Tore
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 134 (01) : 186 - 192
  • [22] CYP2D6 genotype and dextromethorphan hydroxylation phenotype in an Ecuadorian population
    Dorado, Pedro
    Heras, Natalia
    Machin, Esther
    Hernandez, Francisco
    Teran, Enrique
    LLerena, Adrian
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (05) : 637 - 644
  • [23] CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans
    A LLerena
    P Dorado
    R Ramírez
    I González
    M Álvarez
    E M Peñas-LLedó
    B Pérez
    L R Calzadilla
    The Pharmacogenomics Journal, 2012, 12 : 176 - 183
  • [24] CYP2D6 genotype and phenotype determination in a Mexican Mestizo population
    López, M
    Guerrero, J
    Jung-Cook, H
    Alonso, ME
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (10) : 749 - 754
  • [25] CYP2D6 phenotype and genotype in a Canadian Native Indian population
    Nowak, MP
    Tyndale, RF
    Sellers, EM
    PHARMACOGENETICS, 1997, 7 (02): : 145 - 148
  • [26] CYP2D6 genotype and dextromethorphan hydroxylation phenotype in an Ecuadorian population
    Pedro Dorado
    Natalia Heras
    Esther Machín
    Francisco Hernández
    Enrique Teran
    Adrián LLerena
    European Journal of Clinical Pharmacology, 2012, 68 : 637 - 644
  • [27] Genotype/phenotype double expertise for predicting CYP2D6 status
    Serdjebi, C.
    Quaranta, S.
    Solas, C.
    Ciccolini, J.
    Lacarelle, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 81 - 81
  • [28] CYP2D6 genotype and phenotype determination in a Mexican Mestizo population
    Marisol López
    Jorge Guerrero
    Helgi Jung–Cook
    María Elisa Alonso
    European Journal of Clinical Pharmacology, 2005, 61 : 749 - 754
  • [29] Effect of the CYP2D6*10 Genotype on Tolterodine Pharmacokinetics
    Oishi, Masayo
    Chiba, Koji
    Malhotra, Bimal
    Suwa, Toshio
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (09) : 1456 - 1463
  • [30] CYP2D6 genotype related to tamoxifen efficacy: An analysis with exclusion of potential fake CYP2D6 genotype assignment caused by loss of hetcrozygosity in tumor tissue
    Dezentje, Vincent O.
    van Schalk, Ron H. N.
    Vietter-Bogaartz, Judith M.
    van der Straaten, Tahar
    Wessels, Judith A. M.
    Kranertharg, Elma Meershoek-Klein
    Berns, Els M. J. J.
    Seynaeve, Caroline
    Putter, Hein
    Van de Velde, Cornelis J. H.
    Nortier, J. W. R.
    Gelderblom, Hans
    Guchelaar, Henk-jan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345